Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - CEN BIOTECH INC | cenb20200331_10q.htm |
| EX-32.1 - EXHIBIT 32.1 - CEN BIOTECH INC | ex_189867.htm |
| EX-31.2 - EXHIBIT 31.2 - CEN BIOTECH INC | ex_189866.htm |
| EX-31.1 - EXHIBIT 31.1 - CEN BIOTECH INC | ex_189865.htm |
Exhibit 32.2
Section 1350 Certification
In connection with the Quarterly Report on Form 10-Q of CEN Biotech Inc. (the “Company”) for the quarter ended March 31, 2020, as filed with the Securities and Exchange Commission (the “Report”), I Alex Tarrabain, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
|
Date: June 12, 2020 |
/s/Alex Tarrabain |
|
|
|
Alex Tarrabain, Chief Financial Officer (Principal Financial and Accounting Officer) |
|